Toxicophores: groups and metabolic routes associated with increased safety risk
- PMID: 11865664
Toxicophores: groups and metabolic routes associated with increased safety risk
Abstract
Drugs and chemicals can be metabolized in living organisms in an effort to remove them from the body. During this excretion process, certain chemicals can be transformed into unstable, highly reactive species. This can result in the overwhelming of cellular defense, allowing the reactive metabolite to bind to cellular macromolecules, and leading to abnormal cellular function. It is widely accepted that this process can lead to clinically observed toxicities in the form of idiosyncratic adverse drug reactions. However, it is currently impossible to predict which chemical species will cause these reactions. This review focuses on drugs from which reactive metabolites have been detected and reiterates the need for a more thorough understanding of basic drug metabolism before attempting to relate chemical species formation to biological function.
Similar articles
-
Structural alerts, reactive metabolites, and protein covalent binding: how reliable are these attributes as predictors of drug toxicity?Chem Biodivers. 2009 Nov;6(11):2115-37. doi: 10.1002/cbdv.200900055. Chem Biodivers. 2009. PMID: 19937848 Review.
-
Prediction of a new drug's potential to cause idiosyncratic reactions.Curr Opin Drug Discov Devel. 2001 Jan;4(1):55-9. Curr Opin Drug Discov Devel. 2001. PMID: 11727323 Review.
-
Future of toxicology--low-dose toxicology and risk--benefit analysis.Chem Res Toxicol. 2006 Aug;19(8):977-81. doi: 10.1021/tx0601051. Chem Res Toxicol. 2006. PMID: 16918235
-
From toxic precursors to safe drugs. Mechanisms and relevance of idiosyncratic drug reactions.Arzneimittelforschung. 2002;52(6):423-9. doi: 10.1055/s-0031-1299909. Arzneimittelforschung. 2002. PMID: 12109041 Review.
-
Idiosyncratic toxicity: mechanistic insights gained from analysis of prior compounds.Curr Opin Drug Discov Devel. 2005 Jan;8(1):59-65. Curr Opin Drug Discov Devel. 2005. PMID: 15679173 Review.
Cited by
-
MLinvitroTox reloaded for high-throughput hazard-based prioritization of high-resolution mass spectrometry data.J Cheminform. 2025 Jan 31;17(1):14. doi: 10.1186/s13321-025-00950-4. J Cheminform. 2025. PMID: 39891244 Free PMC article.
-
Designing Endocrine Disruption Out of the Next Generation of Chemicals.Green Chem. 2013 Jan;15(1):181-198. doi: 10.1039/C2GC35055F. Green Chem. 2013. PMID: 25110461 Free PMC article.
-
[Delayed-type cutaneous drug reactions. Pathogenesis, clinical features and histology].Hautarzt. 2014 May;65(5):397-408. doi: 10.1007/s00105-013-2696-9. Hautarzt. 2014. PMID: 24820797 German.
-
Metabolomic screening and identification of the bioactivation pathways of ritonavir.Chem Res Toxicol. 2011 Dec 19;24(12):2109-14. doi: 10.1021/tx2004147. Epub 2011 Nov 17. Chem Res Toxicol. 2011. PMID: 22040299 Free PMC article.
-
In-Vitro Approaches to Predict and Study T-Cell Mediated Hypersensitivity to Drugs.Front Immunol. 2021 Apr 13;12:630530. doi: 10.3389/fimmu.2021.630530. eCollection 2021. Front Immunol. 2021. PMID: 33927714 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical